Baxter Highlights New Data at Kidney Week Indicating Sharesource is Associated with a 77% Lower Risk of Home Dialysis Technique Failure
Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, announced today new data indicating Baxter’s Sharesource remote patient management (RPM) digital platform, when used with an automated peritoneal dialysis (PD) system, is associated with a 77% reduction…
ATEC Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Adjusted EBITDA Guidance
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2023, and recent corporate highlights. Third Quarter 2023 Financial Results Quarter EndedSeptember 30,…
Histosonics announces new subsidies for kidney treatment
Histosonics ( www.histosonics.com ), the non-invasive Edison® Histotripsy System and innovative sound wave therapy, is a Medicare – The Centers for Medicaid Services (CMS) announced a new subsidy of $17,500 for histotripsy surgery for liver tumors. In the November 2023 rulemaking process, CMS…
Medifast Announces Third Quarter 2023 Financial Results
Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the third quarter ended September 30, 2023. Third Quarter 2023 “We are adapting our business model to adjust to the rapidly…
DocGo Announces Record Third Quarter 2023 Results
DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended September 30, 2023. Q3 2023 Financial Highlights Select Corporate Highlights 2023 Guidance Lee Bienstock,…
Innate Pharma Announces Conference Call for Third Quarter 2023 Business Update
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the Company will hold a conference call on Tuesday, November 14, 2023, at 2 p.m. CET / 8 a.m. ET, to give an update on…
Aura Biosciences Announces Pricing of Public Offering of Common Stock
Aura Biosciences, Inc. (“Aura”) (Nasdaq: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the pricing of an underwritten public offering of 11,000,000shares of its common stock at…
Chemed Corporation Announces the Retirement of David P. Williams
Chemed Corporation (NYSE: CHE) – After more than three decades, Executive Vice President and Chief Financial Officer David P. Williams has announced that he will retire as Chemed’s Chief Financial Officer as of December 31, 2023, but Mr. Williams will continue to work with Chemed for…
Chemed Corporation Declares Quarterly Dividend of 40 Cents
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 40-cents per share on the Company’s capital stock, payable on December 4, 2023, to shareholders of record as of November 13, 2023. This is equal to the dividend…
Doximity Launches DocDefender, Expanding Services to Safeguard Physician Privacy
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced DocDefender, a free service for physicians that tracks down and eliminates their personal contact information from public websites. In an environment of escalating violence and harassment against…
BOTOX® Cosmetic (onabotulinumtoxinA) Day is Back Like Never Before
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is celebrating the fifth annual BOTOX® Cosmetic Day on Wednesday, November 15. To commemorate this milestone, the brand is expanding its offerings like never before. New and loyal members of Allē, the Allergan Aesthetics loyalty program, have…
Baxter Reports Third-Quarter 2023 Results
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2023. “Baxter continues to successfully execute upon the slate of strategic actions we announced at the outset of 2023,” said José (Joe) E. Almeida,…